pharma
dog
News
when
Latest
Archive
by source
All Sources
Sources Page
Jobs
department
Clinical
Regulatory
Medical Affairs
Commercial
R&D / Discovery
Biostatistics / Data
Manufacturing / CMC
Market Access
therapeutic area
Oncology
Immunology
Neuroscience
Cardiovascular
Metabolic
Rare Disease
Infectious Disease
location & type
Remote Only
US Only
California
Massachusetts
Internships
Phase 3 Roles
All Jobs →
Drugs
by stage
Marketed
Phase 3
Phase 2
Phase 1
Preclinical
browse
Most catalysts
Recently active
All drugs →
Companies
Patent cliff
Calendar
what
Trial readouts
PDUFA dates
Approvals
Earnings
when
Upcoming
Month grid
Recently passed
◐
Sign In
Subscribe
home
jobs
news
search
Approval · news · pharmadog
← back to Approval
News · Approval
1,551
stories
11d
Novocure denied FDA approval for Optune Mya cancer device after efficacy concerns
fiercebiotech
11d
Bayer wins FDA approval for stroke prevention drug Sunharbo
endpoints
11d
Recon: Bayer wins FDA approval for stroke prevention drug; Third Rock enters $2B partnership with AI-focused Chinese biotech
raps
11d
Bayer wins FDA nod for a new kind of blood thinner
biopharma dive
11d
STAT+: FDA approves novel Bayer drug to reduce recurrence of stroke
stat
11d
FDA Approves First Factor Xla Inhibitor to Help Prevent Stroke in Certain Adults at High Risk
fda press
11d
Boehringer, Zealand’s obesity drug doesn’t elevate heart risk in key late-stage test
biospace
11d
Lilly to seek second sleep apnea approval after Foundayo reduces disease severity in Phase 3
biospace
11d
Vir's hepatitis delta combo tamps down virus as Gilead showdown looms
biospace
11d
Vir hepatitis D drug succeeds in first pivotal study
biopharma dive
11d
#AHA26: Boehringer to seek approval of obesity shot, but gaining market share could be tricky
endpoints
11d
Update: Compass submits psilocybin depression drug for approval after stock wobbles
biospace
11d
J&J and Protagonist’s Icotyde improves psoriatic arthritis but AbbVie’s Skyrizi likely to reign
biospace
11d
Ramaswamy’s biotech baggage haunted his political run
biopharma dive
11d
#AHA26: Lilly gets another sleep apnea win, this time with obesity pill
endpoints
11d
Update: FDA investigates Novartis' Zolgensma following 9 cases of tumors in treated patients
biospace
12d
Zura scraps hidradenitis suppurativa program after phase 2 miss, sinking stock
fiercebiotech
12d
J&J-backed Delix drums up $100M series C for non-hallucinatory psychedelic for depression
fiercebiotech
12d
Sanofi-backed Windward breezes toward $204M IPO to fund respiratory pipeline from China
fiercebiotech
12d
With an approval apiece, the verdict is still out on AbbVie’s and BMS’ twin neuro buys
biospace
12d
Vir’s phase 3 hepatitis delta win fuels push to eclipse Gilead
fiercebiotech
14d
Could we see 10 Chinese Big Pharmas within a decade? Some CEOs think so
fiercebiotech
14d
J&J’s Rybrevant nets FDA approval in head and neck cancer
endpoints
14d
Novartis reveals cancer cases possibly linked to gene therapy Zolgensma
biopharma dive
14d
Moderna enjoys stable vaccine sales thanks to global COVID uptake
biospace
14d
STAT+: Amgen’s Repatha linked to fewer heart attacks
stat
14d
Agios axes 100-plus R&D roles while awaiting FDA decision
biospace
14d
Sarepta’s new CEO confident in clinical execution as DMD competitors close in
biospace
14d
Sarepta quits enrolling for confirmatory Phase 3 trial of Elevidys
endpoints
14d
Verdicts for Summit/Akeso, Capricor, Vertex mark FDA’s stacked November
biospace
← prev
page 5 of 52
next →